BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30170380)

  • 1. Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.
    Zhu N; Hou J; Wu Y; Liu J; Li G; Zhao W; Ma G; Chen B; Song Y
    Medicine (Baltimore); 2018 Aug; 97(35):e11887. PubMed ID: 30170380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors.
    Chen K; Bai L; Ji L; Wu L; Li G
    Medicine (Baltimore); 2021 Jun; 100(24):e26271. PubMed ID: 34128858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
    Chen J; Song Y; Li M; Zhang Y; Lin T; Sun J; Wang D; Liu Y; Guo J; Yu W
    BMC Cancer; 2021 Mar; 21(1):255. PubMed ID: 33750326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
    Wang J; Zhang C; Wu Y; He W; Gou X
    Cancer Cell Int; 2019; 19():327. PubMed ID: 31827401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
    Xu Z; Wang C; Xiang X; Li J; Huang J
    Med Sci Monit; 2019 Apr; 25():3041-3060. PubMed ID: 31020952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network.
    Wang J; Ding Y; Wu Y; Wang X
    J Cell Biochem; 2020 Jan; 121(1):876-887. PubMed ID: 31452262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy.
    Xu X; Hao Y; Xiong S; He Z
    Interdiscip Sci; 2020 Dec; 12(4):447-460. PubMed ID: 32876881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
    Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
    DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
    Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
    J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
    Wu X; Liu J; Zhu C; Ma M; Chen X; Liu Y; Xia N; Dong Q
    Med Sci Monit; 2020 Dec; 26():e927725. PubMed ID: 33328429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.